Clarmon Introduces QAvalid v2.0, the New Generation, Web-based Validation and Compliance Management System
Gaithersburg, Maryland, United Stated and Hyderabad, Andhra Pradesh, India. January 23, 2009:
Clarmon Corporation announced today the release of QAvalid 2.0, the latest version of its leading validation and compliance management system.
As a real-life alternative to paper or manual systems, the QAvalid software suite is the optimal solution for Life Science companies focused on standardizing their validation and compliance documentation activities across multiple sites and reducing the cost of compliance. QAvalid ensures that all documents are maintained consistent and controlled and enables users to focus exclusively on critical tasks by automating recurring documentation and compliance processes.
Unlike traditional document management and compliance systems, QAvalid allows users to work directly in the familiar Microsoft Office® interface and thanks to its unique Linksense™ technology still ensures full traceability, drastically reducing the time needed to manage documents. The technology enables users to connect physically separate but related content such as requirements, risk assessments or tests across multiple documents, ensuring that the impact of any change is always visible. Furthermore, an up-to-date traceability matrix can be generated on demand for any set of validation or compliance documents in order to identify gaps or justify the extent of the documentation effort.
The enhancements in version 2.0 are strengthening QAvalid’s position as the most efficient validation management system today and are extending the system’s capabilities to automate all of the main quality management processes. QAvalid 2.0 ensures control and provides the optimal solution to demonstrate regulatory compliance without changing the user’s way of working. Improved information reuse based on master templates, extended integration with 3’rd party systems such as Crystal Reports and extended workflow support for quality system documentation processes increase the product’s time and money saving potential even more.
Ocimum Biosolutions distributes implements and supports Clarmon Corporation’s QAvalid™ – Compliance Management Solution in North America and Asia. Ocimum Biosolutions’ extensive knowledge of Computer Systems Validation requirements and processes as well as its extensive understanding of pharmaceutical and biotechnology laboratories enables them to provide high value to regulated industries seeking effective and efficient validation solutions for their laboratory systems.
About Clarmon
Clarmon Corporation provides advanced software solutions for quality and compliance management. The majority of Clarmon’s customers are Life Science companies that operate inside highly regulated environments. Using Clarmon’s Web and Microsoft Office® based solutions these companies have been able to replace paper and manual systems with a fully electronic, automated environment that reduces the efforts and costs of demonstrating compliance.
QAvalid, Clarmon’s validation and compliance management suite, provides a simple method to centrally manage and control documents without requiring users to re-enter information. Unique technology embedded in QAvalid allows quality professionals to connect and synchronize documents and regulations, drastically reducing the time needed to update documents. Clarmon is a privately owned company established and sustained by people with extensive experience in Compliance Management, Quality Assurance and Validation. For more information about Clarmon Corporation please visit www.clarmon.com
About Ocimum Biosolutions
Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.
We are a preferred outsourcing partner for providing integrated biorepository and genomic services for several global pharmaceutical companies. Our global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating the world’s largest commercial gene expression databases – BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. Our specialty LIMS solution, Biotracker™ caters to the growing needs of core labs in global companies and research centers involved in Life Science Research. We provide multiple GLP-compliant platforms for gene expression and SNP genotyping data generation. We also provide full biorepository and genomic services support for the Genetic Alliance, which is an umbrella organization representing ~600 genetic advocacy groups. Besides providing the physical infrastructure for storing thousands of biological samples, we provide services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.
For more information, please visit www.ocimumbio.com
| Media Contact Dr. Ashwin Sivakumar Director Marketing – Alliances and Outreach Ocimum Biosolutions +91 40 66627200 E-mail: pr@ocimumbio.com |
Investor Contact |
